BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 23070557)

  • 1. Modulation of innate immunity by Toxoplasma gondii virulence effectors.
    Hunter CA; Sibley LD
    Nat Rev Microbiol; 2012 Nov; 10(11):766-78. PubMed ID: 23070557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.
    Fox BA; Rommereim LM; Guevara RB; Falla A; Hortua Triana MA; Sun Y; Bzik DJ
    mBio; 2016 May; 7(3):. PubMed ID: 27165797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have it your way: how polymorphic, injected kinases and pseudokinases enable Toxoplasma to subvert host defenses.
    Boothroyd JC
    PLoS Pathog; 2013; 9(4):e1003296. PubMed ID: 23633947
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic Mapping of Pathogenesis Determinants in Toxoplasma gondii.
    Behnke MS; Dubey JP; Sibley LD
    Annu Rev Microbiol; 2016 Sep; 70():63-81. PubMed ID: 27359216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxoplasma gondii Parasitophorous Vacuole Membrane-Associated Dense Granule Proteins Orchestrate Chronic Infection and GRA12 Underpins Resistance to Host Gamma Interferon.
    Fox BA; Guevara RB; Rommereim LM; Falla A; Bellini V; Pètre G; Rak C; Cantillana V; Dubremetz JF; Cesbron-Delauw MF; Taylor GA; Mercier C; Bzik DJ
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266861
    [No Abstract]   [Full Text] [Related]  

  • 6. Communication between Toxoplasma gondii and its host: impact on parasite growth, development, immune evasion, and virulence.
    Blader IJ; Saeij JP
    APMIS; 2009 May; 117(5-6):458-76. PubMed ID: 19400868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TgTKL1 Is a Unique Plant-Like Nuclear Kinase That Plays an Essential Role in Acute Toxoplasmosis.
    Varberg JM; Coppens I; Arrizabalaga G; Gaji RY
    mBio; 2018 Mar; 9(2):. PubMed ID: 29559568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxoplasma gondii effectors are master regulators of the inflammatory response.
    Melo MB; Jensen KD; Saeij JP
    Trends Parasitol; 2011 Nov; 27(11):487-95. PubMed ID: 21893432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.
    Jensen KD; Camejo A; Melo MB; Cordeiro C; Julien L; Grotenbreg GM; Frickel EM; Ploegh HL; Young L; Saeij JP
    mBio; 2015 Feb; 6(2):e02280. PubMed ID: 25714710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Toxoplasma gondii persistence and latency.
    Sullivan WJ; Jeffers V
    FEMS Microbiol Rev; 2012 May; 36(3):717-33. PubMed ID: 22091606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in imaging the innate and adaptive immune response to Toxoplasma gondii.
    John B; Weninger W; Hunter CA
    Future Microbiol; 2010 Sep; 5(9):1321-8. PubMed ID: 20860479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Human Innate Immune Evasion by
    Lima TS; Lodoen MB
    Front Cell Infect Microbiol; 2019; 9():103. PubMed ID: 31041194
    [No Abstract]   [Full Text] [Related]  

  • 13. The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.
    Etheridge RD; Alaganan A; Tang K; Lou HJ; Turk BE; Sibley LD
    Cell Host Microbe; 2014 May; 15(5):537-50. PubMed ID: 24832449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of ROP18 and ROP5 was efficient as a marker of virulence in atypical isolates of Toxoplasma gondii obtained from pigs and goats in Piauí, Brazil.
    Rêgo WMF; Costa JGL; Baraviera RCA; Pinto LV; Bessa GL; Lopes REN; Vitor RWA
    Vet Parasitol; 2017 Nov; 247():19-25. PubMed ID: 29080759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men.
    Gazzinelli RT; Mendonça-Neto R; Lilue J; Howard J; Sher A
    Cell Host Microbe; 2014 Feb; 15(2):132-8. PubMed ID: 24528860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism for the control of virulent Toxoplasma gondii infections in wild-derived mice.
    Murillo-León M; Müller UB; Zimmermann I; Singh S; Widdershooven P; Campos C; Alvarez C; Könen-Waisman S; Lukes N; Ruzsics Z; Howard JC; Schwemmle M; Steinfeldt T
    Nat Commun; 2019 Mar; 10(1):1233. PubMed ID: 30874554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antigens of Toxoplasma gondii].
    Długońska H; Dytnerska K
    Wiad Parazytol; 2000; 46(3):327-34. PubMed ID: 16883687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of Toxoplasma gondii.
    Wong SY; Remington JS
    AIDS; 1993 Mar; 7(3):299-316. PubMed ID: 8471191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasma gondii ROP17 inhibits the innate immune response of HEK293T cells to promote its survival.
    Li JX; He JJ; Elsheikha HM; Chen D; Zhai BT; Zhu XQ; Yan HK
    Parasitol Res; 2019 Mar; 118(3):783-792. PubMed ID: 30675671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections.
    Pittman KJ; Knoll LJ
    Microbiol Mol Biol Rev; 2015 Dec; 79(4):387-401. PubMed ID: 26335719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.